DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 3	2026-07-20		NCT07712848

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Qinghai University	22
Department of Hematology, Guizhou Provincial People's Hospital	1
Department of Hematology, Handan Central Hospital	1
Department of Hematology, Oncology Center, Tianjin Union Medical Center of Nankai University	1
Department of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University	1
Department of Hematology, The First Affiliated Hospital of Guangxi Medical University	1
Department of Hematology, The Second Xiangya Hospital, Central South University	1
People's Hospital of Guangxi Zhuang Autonomous Region	20
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chines	1
The Second Affiliated Hospital of Kunming Medical University	33

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Second Affiliated Hospital of Kunming Medical University	Kunming	China	2